224 related articles for article (PubMed ID: 30009188)
21. Dendritic cells as therapeutic vaccines against cancer.
Banchereau J; Palucka AK
Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
[TBL] [Abstract][Full Text] [Related]
22. Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy.
Zheng R; Kjaergaard J; Lee WT; Cohen PA; Shu S
Cancer Treat Res; 2007; 135():223-37. PubMed ID: 17953420
[No Abstract] [Full Text] [Related]
23. Towards a rational approach to vaccine development.
Leclerc C
Hum Vaccin; 2010 Apr; 6(4):292-6. PubMed ID: 20372073
[No Abstract] [Full Text] [Related]
24. New era of regulatory T cells in tumor immunity: insights in cancer immunotherapy.
Sheu BC; Chang WC; Huang SC
J Formos Med Assoc; 2010 Jan; 109(1):1-3. PubMed ID: 20123581
[No Abstract] [Full Text] [Related]
25. Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity.
Xia D; Li F; Xiang J
Cancer Biother Radiopharm; 2004 Jun; 19(3):322-30. PubMed ID: 15285878
[TBL] [Abstract][Full Text] [Related]
26. [Cancer immunotherapy via systemic RNA delivery to dendritic cells].
Richaud M; Bendriss-Vermare N
Med Sci (Paris); 2017 Oct; 33(10):852-856. PubMed ID: 28994378
[No Abstract] [Full Text] [Related]
27. Dendritic cells in tumor immunology and immunotherapy.
Turtle CJ; Hart DN
Curr Drug Targets; 2004 Jan; 5(1):17-39. PubMed ID: 14738216
[TBL] [Abstract][Full Text] [Related]
28. Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma.
Clavijo-Salomon MA; Bergami-Santos PC; M Barbuto JA
Immunotherapy; 2017 Mar; 9(4):319-329. PubMed ID: 28303767
[TBL] [Abstract][Full Text] [Related]
29. Immune based therapies in cancer.
Krüger C; Greten TF; Korangy F
Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
[TBL] [Abstract][Full Text] [Related]
30. The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.
López M; Aguilera R; Pérez C; Mendoza-Naranjo A; Pereda C; Ramirez M; Ferrada C; Aguillón JC; Salazar-Onfray F
Immunobiology; 2006; 211(1-2):127-36. PubMed ID: 16446177
[TBL] [Abstract][Full Text] [Related]
31. Cancer vaccines: the state of the art.
Finn OO; Banchereau J
Semin Immunol; 2010 Jun; 22(3):103-4. PubMed ID: 20552730
[No Abstract] [Full Text] [Related]
32. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].
Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG
Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974
[TBL] [Abstract][Full Text] [Related]
33. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients.
Alfaro C; Perez-Gracia JL; Suarez N; Rodriguez J; Fernandez de Sanmamed M; Sangro B; Martin-Algarra S; Calvo A; Redrado M; Agliano A; Gonzalez A; Rodriguez I; Bolaños E; Hervás-Stubbs S; Perez-Calvo J; Benito A; Peñuelas I; Vigil C; Richter J; Martinez-Forero I; Melero I
J Immunol; 2011 Dec; 187(11):6130-42. PubMed ID: 22048768
[TBL] [Abstract][Full Text] [Related]
34. The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24-26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy.
Signori E; Cavallo F
Cancer Immunol Immunother; 2015 Oct; 64(10):1349-56. PubMed ID: 25762082
[No Abstract] [Full Text] [Related]
35. NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge.
Bouwer AL; Saunderson SC; Caldwell FJ; Damani TT; Pelham SJ; Dunn AC; Jack RW; Stoitzner P; McLellan AD
J Immunol; 2014 Mar; 192(5):2514-21. PubMed ID: 24477907
[TBL] [Abstract][Full Text] [Related]
36. Cell fusion: from hybridoma to dendritic cell-based vaccine.
Gong J; Koido S; Calderwood SK
Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954
[TBL] [Abstract][Full Text] [Related]
37. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
38. Role of CD4+ T lymphocytes in antitumor immunity.
Rajnavölgyi E; Lányi A
Adv Cancer Res; 2003; 87():195-249. PubMed ID: 12641277
[No Abstract] [Full Text] [Related]
39. [From dendritic cells to the exosomes that they secrete: a decisive advance for anticancer vaccine therapy?].
Jeanteur P
Bull Cancer; 1998 Jun; 85(6):521. PubMed ID: 9752278
[No Abstract] [Full Text] [Related]
40. Dendritic cells: a journey from laboratory to clinic.
Cerundolo V; Hermans IF; Salio M
Nat Immunol; 2004 Jan; 5(1):7-10. PubMed ID: 14699398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
